Yasmine Wasfi
Chief Medical OfficerDr. Yasmine Wasf, M.D. P.hd., is Chief Medical Officer of Savara Inc. from October 17, 2025 and was its Executive VP and Head of Clinical Development & Clinical Operations from July 2024 to October 17, 2025. Dr. Wasfi was Senior VP & Head of Clinical Development of Savara Inc. from December 2023 to July 2024. With over two decades of industry and healthcare experience, Yasmine is a seasoned professional within clinical research and drug development of both large and small molecule novel therapeutics. Her clinical development work includes respiratory drug development and late-phase immunology clinical development. Dr. Wasfi has held roles of increasing responsibility within large pharmaceutical and smaller biotech companies, including Amicus Therapeutics, Johnson & Johnson and Merck. She received a B. A. in Biology from the University of Delaware, M. D. from the University of Pennsylvania School of Medicine and Ph. D. in Clinical Science from the University of Colorado Health Sciences Center. She completed her internship and residency in internal medicine at the Hospital of the University of Pennsylvania and her fellowship in Pulmonary and Critical Care at the University of Colorado Health Sciences Center.
Positions
- Company NameSavara Inc.Stock CodeSVRAPositionChief Medical OfficerColleagues
